IMM-H014
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for IMM-H014, covering 2025-04-11 to 2025-06-13. Get the full timeline:
Most recent: Clinical Trial Update: To Evaluate the Tolerability, Pharmacokinetics, and Pharmacodynamics of IMM-H014 in Patients With MASH [Phase 1, Phase 2]